SG Americas Securities’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24K Buy
1,834
+227
+14% +$5.07K ﹤0.01% 3257
2026
Q1
$42K Buy
1,607
+680
+73% +$85.5K ﹤0.01% 3040
2025
Q4
$230K Buy
927
+662
+250% +$151K ﹤0.01% 2871
2025
Q3
$56K Buy
+265
New +$46.7K ﹤0.01% 3187
2024
Q2
– Sell
-357
Closed -$34K – 3028
2024
Q1
$34K Buy
+357
New +$31.4K ﹤0.01% 2821
2023
Q2
– Sell
-2,085
Closed -$210K – 2627
2023
Q1
$210K Buy
+2,085
New +$319K ﹤0.01% 2385
2022
Q4
– Sell
-171
Closed -$164K – 3174
2022
Q3
$164K Sell
171
-185
-52% -$184K ﹤0.01% 2480
2022
Q2
$238K Buy
356
+177
+99% +$110K ﹤0.01% 2542
2022
Q1
$124K Sell
179
-76
-30% -$58.6K ﹤0.01% 2678
2021
Q4
$231K Sell
255
-355
-58% -$337K ﹤0.01% 2598
2021
Q3
$614K Buy
+610
New +$449K ﹤0.01% 2327
2021
Q2
– Sell
-160
Closed -$118K – 2994
2021
Q1
$118K Buy
+160
New +$129K ﹤0.01% 3000
2020
Q4
– Sell
-314
Closed -$311K – 3390
2020
Q3
$311K Sell
314
-372
-54% -$395K ﹤0.01% 1918
2020
Q2
$714K Buy
+686
New +$690K 0.01% 1750

Other funds holding GOSS

SG Americas Securities's GOSS Position: Q2 2026 in Review

SG Americas Securities increased its Gossamer Bio (GOSS) stake by 14% in Q2 2026, buying an estimated $5.07K and bringing the position to 1,834 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #3257.

SG Americas Securities first reported a position in GOSS in Q2 2020 and has held it in 14 quarters since. The position peaked at $714K in Q2 2020. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • SG Americas Securities held 1,834 shares of Gossamer Bio worth $24K as of Q2 2026.
  • SG Americas Securities bought 227 Gossamer Bio shares in Q2 2026, an estimated $5.07K.
  • Gossamer Bio made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3257 holding.
  • SG Americas Securities first reported a position in Gossamer Bio in Q2 2020 and has held it in 14 quarters since.
  • SG Americas Securities's Gossamer Bio position peaked at $714K in Q2 2020.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.